Williams Brinkley Ruth
SEC CIK 1344381 · EDGAR
Most active insiders at TVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dube Eric M | CEO, Dir | — | $41.35M |
| 2 | Heerma Peter | EVP, Chief COMMERCIAL Off | — | $18.97M |
| 3 | ROTE WILLIAM E. | Chief Research Off | — | $16.43M |
| 4 | REED ELIZABETH E | CLO, GC | — | $7.02M |
| 5 | Inrig Jula | EVP, CMO, Head of R, D | — | $5.16M |
| 6 | Cline Christopher R. | CFO | — | $4.64M |
| 7 | Calvin Sandra | SVP, CAO | — | $4.19M |
| 8 | Baynes Roy D. | Dir | — | $2.55M |
| 9 | Meckler Jeffrey A | Dir | — | $1.71M |
| 10 | Coughlin Timothy | Dir | — | $1.27M |
| 16 | Williams Brinkley Ruth | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Travere Therapeutics, Inc. | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +4,000 | 29.8K | +16% | $0 |
| 2026-04-28 20:35 | 2026-04-24 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +86 | 5,475 | +2% | — | |
| 2026-02-03 | 2026-01-30 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +73 | 5,389 | +1% | — | |
| 2025-11-04 | 2025-10-31 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +97 | 5,316 | +2% | — | |
| 2025-07-29 | 2025-07-25 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +112 | 5,219 | +2% | — | |
| 2025-07-01 | 2025-06-27 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +2,143 | 5,107 | +72% | — | |
| D | 2025-05-16 | 2025-05-15 | TVTX | Travere Therapeutics, Inc. | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +6,500 | 25.8K | +34% | $0 |
| 2024-07-02 | 2024-06-28 | NTRA | Natera, Inc. | Williams Brinkley Ruth | Dir | A - Grant | — | +2,964 | 2,964 | New | — | |
| D | 2024-05-10 | 2024-05-08 | TVTX | Travere Therapeutics, Inc. | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +6,500 | 19.2K | +51% | $0 |
| D | 2023-05-19 | 2023-05-17 | TVTX | Travere Therapeutics, Inc. | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +4,500 | 12.8K | +55% | $0 |
| D | 2022-05-12 | 2022-05-11 | TVTX | Travere Therapeutics, Inc. | Williams Brinkley Ruth | Dir | A - Grant | $0.00 | +3,000 | 8,250 | +57% | $0 |
| D | 2021-09-16 | 2021-09-14 | TVTX | Travere Therapeutics, Inc. | Brinkley Ruth Williams | Dir | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations